HOPA News

HOPA News is the association news materials featuring clinical content, practice management information, pharmacy and association events, and news important to all pharmacists who work in hematology/oncology. The Editorial Board is composed of members who serve on the Publications Committee and act as writers, editors, and peer reviewers.

HOPA News Archive

The Emerging Role of Minimal Residual Disease in Multiple Myeloma

Past Newsletters

2024

The Future Has Arrived: Gene Therapy for Sickle Cell Disease
New Horizons for Resectable Non-Small Cell Lung Cancer: Updates in Perioperative Treatment

2023

Lymphoma Bispecific T-cell Engagers’ Place in Therapy
Indication Withdrawls of Small Molecule Inhibitors from the Accelerated Approval Program
Importance of Cancer Pain Management
Putting All of Our Eggs in Baskets Trials: New Tumor-Agnostic Approvals

2022

Overcoming Challenges to Provide BiTe and Car T Cell Therapy at a Community Career Center
Clinical Trial Management in the Post-Pandemic Era:  Reflections of an Investigational Drug Service  on the Past Two Years
B-Cell Maturation Antigen Targeting CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
The Blood Stops Here: Management of  Pediatric Hemophilia in 2022

2021

The FDA Accelerated Approval Program:  A Double Edged Sword
Up in Flames: Burnout in Oncology Pharmacy
Vials of Hope:  COVID-19 Vaccines for Cancer Patients
Launching an Oral Chemotherapy Telehealth  Clinic Using the TAMER Model

2020

Oncology Pharmacy and COVID-19: Perspectives from an Early Epicenter
Pharmacist Led Oncology Programs
Canabidiol Oil for Cancer Patients: Nature's Best Remedy?
Early Detection Saves Lives: Updates on Cancer Screening